Sri Lanka vs Sur: Previously treated cases tested for RR-/MDR-TB
Sri Lanka
100.0%
in 2024
Sur
62.0%
in 2024
Sri Lanka rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Sri Lanka
- Sur
How they compare
Sri Lanka currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Sri Lanka's figure about 1.6 times Sur's.
The two have swapped places 6 times across 16 shared years of data; in 2005 it was Sri Lanka ahead.
Sri Lanka ranks 1st and Sur ranks 2nd of 180 countries.
Across the 3 decades both report, Sri Lanka averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Sri Lanka | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.0% | 14.3% | 73.7% | Sri Lanka |
| 2010s | 84.1% | 53.0% | 31.1% | Sri Lanka |
| 2020s | 81.5% | 82.5% | 1.0% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sri Lanka or Sur?
- Sri Lanka, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sri Lanka and Sur?
- 38.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Sur?
- 16 years are reported by both, from 2005 to 2024.
- How do Sri Lanka and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Sri Lanka ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.